Skip to main content

Provider

By Jessica Hagen | 10:00 am | December 12, 2024
Tuva's CEO told MobiHealthNews that the company operates by "open-sourcing" the specialized knowledge needed to transform healthcare data and embedding that knowledge into an analytics-ready data model.
By HIMSS TV | 05:32 pm | December 11, 2024
When considering a merger or acquisition, potential buyers should ask for the seller’s security policies and procedures, a risk analysis, and whether they have had recent security incidents, says Adam Greene, partner at Davis Wright Tremaine.
By Jessica Hagen | 01:37 pm | December 11, 2024
The tracker highlights youth mental health across the U.S. through data, stories and surveys. A related white paper offers recommendations for policymakers.
By Jessica Hagen | 12:43 pm | December 11, 2024
The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.
By HIMSS TV | 11:35 am | December 11, 2024
People in the workforce are increasingly looking for work-life harmony. Flex work is very much in demand, says Robert Crowe, EVP of per diem and local workforce strategies at Medical Solutions and founder of Matchwell.
By HIMSS TV | 05:37 pm | December 10, 2024
To defend against attacks from ransomware players like Scattered Spider, HHS provides goals to help organizations improve their cybersecurity posture, says Troy Adams, cyber engagement specialist, Department of Health and Human Services.
By Jessica Hagen | 01:39 pm | December 10, 2024
The Series B extension brings the round to $35 million, raising Hyro's total funding to $50 million.
By HIMSS TV | 10:27 am | December 10, 2024
Andre Esteva, CEO and cofounder of Artera, a spin-out of Salesforce, relays how the company's AI tool looks at images of cancer tumors and recommends specific therapies to clinicians.
By HIMSS TV | 06:09 pm | December 09, 2024
It's important that Congress take action on the telehealth and remote patient monitoring extensions from the pandemic that officially expire on December 31, says Tom Leary, senior vice president and head of government relations at HIMSS.
By Jessica Hagen | 05:59 pm | December 09, 2024
The company will use the funds to accelerate the commercialization of its TAPS therapy and enhance the visibility of its offerings among providers and patients.